1h Free Analyst Time
The gastrointestinal over-the-counter (OTC) drugs market is forecasted to grow by USD 5.26 billion during 2023-2028, accelerating at a CAGR of 5.55% during the forecast period. The report on the gastrointestinal over-the-counter (OTC) drugs market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.Speak directly to the analyst to clarify any post sales queries you may have.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increase in prevalence of gastrointestinal disorders, easy availability and affordability of gastrointestinal OTC drugs, and availability of multiple payment options.
The gastrointestinal over-the-counter (OTC) drugs market is segmented as below:
By Product
- Antacid
- Laxatives
- Anti-diarrheal
- Anti-emetics
- Others
By Distribution Channel
- Offline
- Online
By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
The report on the gastrointestinal over-the-counter (OTC) drugs market covers the following areas:
- Gastrointestinal over-the-counter (OTC) drugs market sizing
- Gastrointestinal over-the-counter (OTC) drugs market forecast
- Gastrointestinal over-the-counter (OTC) drugs market industry analysis
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.
Table of Contents
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by Distribution Channel
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Opportunity/Restraints
11 Competitive Landscape
12 Competitive Analysis
13 Appendix
List of Exhibits
Executive Summary
The following companies are recognized as the key players in the global gastrointestinal over-the-counter (OTC) drugs market: Abbott Laboratories, AbbVie Inc., Bausch Health Companies Inc., Bayer AG, Boehringer Ingelheim International GmbH, Cipla Inc., Dr Reddys Laboratories Ltd., Eisai Co. Ltd., GlaxoSmithKline Plc, Haleon Plc, Johnson and Johnson Services Inc., Merck KGaA, Novartis AG, Pfizer Inc., Phathom Pharmaceuticals Inc., Prestige Consumer Healthcare Inc., Sanofi SA, SonoScape Medical Corp., Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Vee Excel Drugs And Pharmaceuticals Pvt. Ltd., and Zoic Pharmaceuticals Pvt. Ltd..Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is increase in adoption of online platforms for gastrointestinal OTC drugs."
According to the report, one of the major drivers for this market is the increase in prevalence of gastrointestinal disorders.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Abbott Laboratories
- AbbVie Inc.
- Bausch Health Companies Inc.
- Bayer AG
- Boehringer Ingelheim International GmbH
- Cipla Inc.
- Dr Reddys Laboratories Ltd.
- Eisai Co. Ltd.
- GlaxoSmithKline Plc
- Haleon Plc
- Johnson and Johnson Services Inc.
- Merck KGaA
- Novartis AG
- Pfizer Inc.
- Phathom Pharmaceuticals Inc.
- Prestige Consumer Healthcare Inc.
- Sanofi SA
- SonoScape Medical Corp.
- Sun Pharmaceutical Industries Ltd.
- Takeda Pharmaceutical Co. Ltd.
- Vee Excel Drugs And Pharmaceuticals Pvt. Ltd.
- Zoic Pharmaceuticals Pvt. Ltd.
